Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
Molecules | Free Full-Text | Kinetic Model of Diclofenac Degradation Developed Using Multivariate Curve Resolution Method
DICLOFENAC POTASSIUM 50 MG + METAXALONE 400 MG
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases